HAMILTON JAMES C sold 18.9% of their position (40.16K shares) of ARROWHEAD PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $2.53M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−4.63K
Price / share
$61.24
Trade value
$283.24K
% of position
Common Stock
Shares
−6.09K
Price / share
$62.28
Trade value
$379.29K
% of position
Common Stock
Shares
−14.79K
Price / share
$63.01
Trade value
$932.04K
% of position
Common Stock
Shares
−12.71K
Price / share
$63.95
Trade value
$812.87K
% of position
Common Stock
Shares
−1.20K
Price / share
$64.49
Trade value
$77.39K
% of position
Common Stock
Shares
−437.00
Price / share
$65.97
Trade value
$28.83K
% of position
Common Stock
Shares
−309.00
Price / share
$68.00
Trade value
$21.01K
% of position
Net shares
−40.16K
Net value
-$2.53M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2026 | S · Sale | −4.63K | $61.24 | $283.24K | 2.2% | 212.12K | 207.50K |
| Common Stock Direct | 1/5/2026 | S · Sale | −6.09K | $62.28 | $379.29K | 2.9% | 207.50K | 201.41K |
| Common Stock Direct | 1/5/2026 | S · Sale | −14.79K | $63.01 | $932.04K | 7.3% | 201.41K | 186.62K |
| Common Stock Direct | 1/5/2026 | S · Sale | −12.71K | $63.95 | $812.87K | 6.8% | 186.62K | 173.90K |
| Common Stock Direct | 1/5/2026 | S · Sale | −1.20K | $64.49 | $77.39K | 0.7% | 173.90K | 172.70K |
| Common Stock Direct | 1/5/2026 | S · Sale | −437.00 | $65.97 | $28.83K | 0.3% | 172.70K | 172.27K |
| Common Stock Direct | 1/5/2026 | S · Sale | −309.00 | $68.00 | $21.01K | 0.2% | 172.27K | 171.96K |
| Total | −40.16K | -$2.53M | ||||||